0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point of Care and Rapid Diagnostic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-29F9566
Home | Market Reports | Health| Medical Facilities & Services
Global Point of Care and Rapid Diagnostic Market Insights Forecast to 2028
BUY CHAPTERS

Global Point of Care and Rapid Diagnostic Market Research Report 2025

Code: QYRE-Auto-29F9566
Report
July 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Point of Care and Rapid Diagnostic Market Size

The global market for Point of Care and Rapid Diagnostic was valued at US$ 21110 million in the year 2024 and is projected to reach a revised size of US$ 34110 million by 2031, growing at a CAGR of 7.2% during the forecast period.

Point of Care and Rapid Diagnostic Market

Point of Care and Rapid Diagnostic Market

Point-of-care (POC) and Rapid Diagnostic is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
The Point of Care and Rapid Diagnostic market is primarily driven by the rising demand for rapid and accessible diagnostic solutions. This demand is fueled by the need for quicker decision-making in healthcare, especially in remote or resource-constrained settings. Additionally, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is propelling the adoption of POCT devices for monitoring and early detection. Moreover, the emphasis on decentralized healthcare and patient-centric approaches is pushing the market to develop more user-friendly and efficient POCT solutions.
While the key challenges facing the POCT product and device market is the necessity for strict regulatory compliance and quality assurance. Ensuring that POCT devices meet regulatory standards and maintain accuracy and reliability is critical for patient safety and effective healthcare delivery. Additionally, challenges related to data management, connectivity, and integration with electronic health records need to be addressed to fully leverage the potential of POCT in improving healthcare outcomes. Balancing ease of use with regulatory compliance remains a pivotal challenge for manufacturers in this rapidly evolving market.The major global manufacturers of Point of Care and Rapid Diagnostic include Abbott, Roche, Danaher, Siemens Healthineers, QuidelOrtho, LifeScan, Wondfo, BioMerieux, Ascensia, ARKRAY, etc. In 2023, the world's top five vendors accounted for approximately 73.47% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Point of Care and Rapid Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care and Rapid Diagnostic.
The Point of Care and Rapid Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point of Care and Rapid Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care and Rapid Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Point of Care and Rapid Diagnostic Market Report

Report Metric Details
Report Name Point of Care and Rapid Diagnostic Market
Accounted market size in year US$ 21110 million
Forecasted market size in 2031 US$ 34110 million
CAGR 7.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinic
  • Laboratory
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY, Bio-Rad Laboratories, Nova Biomedical, QuidelOrtho, Accriva, OraSure Technologies, Helena Laboratories, Phamatech, Chembio Diagnostics, Trinity Biotech, Wuhan Easy Diagnosis, Intec PRODUCT, Sinocare, Wondfo, Getein Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Point of Care and Rapid Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Point of Care and Rapid Diagnostic Market growing?

Ans: The Point of Care and Rapid Diagnostic Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the Point of Care and Rapid Diagnostic Market size in 2031?

Ans: The Point of Care and Rapid Diagnostic Market size in 2031 will be US$ 34110 million.

Who are the main players in the Point of Care and Rapid Diagnostic Market report?

Ans: The main players in the Point of Care and Rapid Diagnostic Market are Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY, Bio-Rad Laboratories, Nova Biomedical, QuidelOrtho, Accriva, OraSure Technologies, Helena Laboratories, Phamatech, Chembio Diagnostics, Trinity Biotech, Wuhan Easy Diagnosis, Intec PRODUCT, Sinocare, Wondfo, Getein Biotech

What are the Application segmentation covered in the Point of Care and Rapid Diagnostic Market report?

Ans: The Applications covered in the Point of Care and Rapid Diagnostic Market report are Hospitals, Clinic, Laboratory, Other

What are the Type segmentation covered in the Point of Care and Rapid Diagnostic Market report?

Ans: The Types covered in the Point of Care and Rapid Diagnostic Market report are Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Urinalysis Testing, Other

Recommended Reports

Core POCT Diagnostics

Specialized POCT Segments

Molecular & Infectious POCT

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care and Rapid Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.2.9 Other
1.3 Market by Application
1.3.1 Global Point of Care and Rapid Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care and Rapid Diagnostic Market Perspective (2020-2031)
2.2 Global Point of Care and Rapid Diagnostic Growth Trends by Region
2.2.1 Global Point of Care and Rapid Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point of Care and Rapid Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Point of Care and Rapid Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Point of Care and Rapid Diagnostic Market Dynamics
2.3.1 Point of Care and Rapid Diagnostic Industry Trends
2.3.2 Point of Care and Rapid Diagnostic Market Drivers
2.3.3 Point of Care and Rapid Diagnostic Market Challenges
2.3.4 Point of Care and Rapid Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care and Rapid Diagnostic Players by Revenue
3.1.1 Global Top Point of Care and Rapid Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Point of Care and Rapid Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Point of Care and Rapid Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point of Care and Rapid Diagnostic Revenue
3.4 Global Point of Care and Rapid Diagnostic Market Concentration Ratio
3.4.1 Global Point of Care and Rapid Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care and Rapid Diagnostic Revenue in 2024
3.5 Global Key Players of Point of Care and Rapid Diagnostic Head office and Area Served
3.6 Global Key Players of Point of Care and Rapid Diagnostic, Product and Application
3.7 Global Key Players of Point of Care and Rapid Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care and Rapid Diagnostic Breakdown Data by Type
4.1 Global Point of Care and Rapid Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Point of Care and Rapid Diagnostic Forecasted Market Size by Type (2026-2031)
5 Point of Care and Rapid Diagnostic Breakdown Data by Application
5.1 Global Point of Care and Rapid Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Point of Care and Rapid Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point of Care and Rapid Diagnostic Market Size (2020-2031)
6.2 North America Point of Care and Rapid Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point of Care and Rapid Diagnostic Market Size by Country (2020-2025)
6.4 North America Point of Care and Rapid Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care and Rapid Diagnostic Market Size (2020-2031)
7.2 Europe Point of Care and Rapid Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point of Care and Rapid Diagnostic Market Size by Country (2020-2025)
7.4 Europe Point of Care and Rapid Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care and Rapid Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Point of Care and Rapid Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point of Care and Rapid Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Point of Care and Rapid Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care and Rapid Diagnostic Market Size (2020-2031)
9.2 Latin America Point of Care and Rapid Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point of Care and Rapid Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Point of Care and Rapid Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care and Rapid Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Point of Care and Rapid Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point of Care and Rapid Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Point of Care and Rapid Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Point of Care and Rapid Diagnostic Introduction
11.1.4 Roche Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Point of Care and Rapid Diagnostic Introduction
11.2.4 Abbott Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 LifeScan
11.3.1 LifeScan Company Details
11.3.2 LifeScan Business Overview
11.3.3 LifeScan Point of Care and Rapid Diagnostic Introduction
11.3.4 LifeScan Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.3.5 LifeScan Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point of Care and Rapid Diagnostic Introduction
11.4.4 Siemens Healthineers Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.4.5 Siemens Healthineers Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Point of Care and Rapid Diagnostic Introduction
11.5.4 Danaher Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.5.5 Danaher Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Details
11.6.2 Ascensia Business Overview
11.6.3 Ascensia Point of Care and Rapid Diagnostic Introduction
11.6.4 Ascensia Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.6.5 Ascensia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Point of Care and Rapid Diagnostic Introduction
11.7.4 BioMerieux Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.7.5 BioMerieux Recent Development
11.8 ARKRAY
11.8.1 ARKRAY Company Details
11.8.2 ARKRAY Business Overview
11.8.3 ARKRAY Point of Care and Rapid Diagnostic Introduction
11.8.4 ARKRAY Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.8.5 ARKRAY Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Point of Care and Rapid Diagnostic Introduction
11.9.4 Bio-Rad Laboratories Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Nova Biomedical
11.10.1 Nova Biomedical Company Details
11.10.2 Nova Biomedical Business Overview
11.10.3 Nova Biomedical Point of Care and Rapid Diagnostic Introduction
11.10.4 Nova Biomedical Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.10.5 Nova Biomedical Recent Development
11.11 QuidelOrtho
11.11.1 QuidelOrtho Company Details
11.11.2 QuidelOrtho Business Overview
11.11.3 QuidelOrtho Point of Care and Rapid Diagnostic Introduction
11.11.4 QuidelOrtho Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.11.5 QuidelOrtho Recent Development
11.12 Accriva
11.12.1 Accriva Company Details
11.12.2 Accriva Business Overview
11.12.3 Accriva Point of Care and Rapid Diagnostic Introduction
11.12.4 Accriva Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.12.5 Accriva Recent Development
11.13 OraSure Technologies
11.13.1 OraSure Technologies Company Details
11.13.2 OraSure Technologies Business Overview
11.13.3 OraSure Technologies Point of Care and Rapid Diagnostic Introduction
11.13.4 OraSure Technologies Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.13.5 OraSure Technologies Recent Development
11.14 Helena Laboratories
11.14.1 Helena Laboratories Company Details
11.14.2 Helena Laboratories Business Overview
11.14.3 Helena Laboratories Point of Care and Rapid Diagnostic Introduction
11.14.4 Helena Laboratories Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.14.5 Helena Laboratories Recent Development
11.15 Phamatech
11.15.1 Phamatech Company Details
11.15.2 Phamatech Business Overview
11.15.3 Phamatech Point of Care and Rapid Diagnostic Introduction
11.15.4 Phamatech Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.15.5 Phamatech Recent Development
11.16 Chembio Diagnostics
11.16.1 Chembio Diagnostics Company Details
11.16.2 Chembio Diagnostics Business Overview
11.16.3 Chembio Diagnostics Point of Care and Rapid Diagnostic Introduction
11.16.4 Chembio Diagnostics Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.16.5 Chembio Diagnostics Recent Development
11.17 Trinity Biotech
11.17.1 Trinity Biotech Company Details
11.17.2 Trinity Biotech Business Overview
11.17.3 Trinity Biotech Point of Care and Rapid Diagnostic Introduction
11.17.4 Trinity Biotech Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.17.5 Trinity Biotech Recent Development
11.18 Wuhan Easy Diagnosis
11.18.1 Wuhan Easy Diagnosis Company Details
11.18.2 Wuhan Easy Diagnosis Business Overview
11.18.3 Wuhan Easy Diagnosis Point of Care and Rapid Diagnostic Introduction
11.18.4 Wuhan Easy Diagnosis Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.18.5 Wuhan Easy Diagnosis Recent Development
11.19 Intec PRODUCT
11.19.1 Intec PRODUCT Company Details
11.19.2 Intec PRODUCT Business Overview
11.19.3 Intec PRODUCT Point of Care and Rapid Diagnostic Introduction
11.19.4 Intec PRODUCT Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.19.5 Intec PRODUCT Recent Development
11.20 Sinocare
11.20.1 Sinocare Company Details
11.20.2 Sinocare Business Overview
11.20.3 Sinocare Point of Care and Rapid Diagnostic Introduction
11.20.4 Sinocare Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.20.5 Sinocare Recent Development
11.21 Wondfo
11.21.1 Wondfo Company Details
11.21.2 Wondfo Business Overview
11.21.3 Wondfo Point of Care and Rapid Diagnostic Introduction
11.21.4 Wondfo Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.21.5 Wondfo Recent Development
11.22 Getein Biotech
11.22.1 Getein Biotech Company Details
11.22.2 Getein Biotech Business Overview
11.22.3 Getein Biotech Point of Care and Rapid Diagnostic Introduction
11.22.4 Getein Biotech Revenue in Point of Care and Rapid Diagnostic Business (2020-2025)
11.22.5 Getein Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Point of Care and Rapid Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Blood Glucose Testing
 Table 3. Key Players of Infectious Diseases Testing
 Table 4. Key Players of Cardiac Markers Testing
 Table 5. Key Players of Coagulation Testing
 Table 6. Key Players of Pregnancy and Fertility Testing
 Table 7. Key Players of Blood Gas/Electrolytes Testing
 Table 8. Key Players of Urinalysis Testing
 Table 9. Global Point of Care and Rapid Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Point of Care and Rapid Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Point of Care and Rapid Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Point of Care and Rapid Diagnostic Market Share by Region (2020-2025)
 Table 13. Global Point of Care and Rapid Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Point of Care and Rapid Diagnostic Market Share by Region (2026-2031)
 Table 15. Point of Care and Rapid Diagnostic Market Trends
 Table 16. Point of Care and Rapid Diagnostic Market Drivers
 Table 17. Point of Care and Rapid Diagnostic Market Challenges
 Table 18. Point of Care and Rapid Diagnostic Market Restraints
 Table 19. Global Point of Care and Rapid Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Point of Care and Rapid Diagnostic Market Share by Players (2020-2025)
 Table 21. Global Top Point of Care and Rapid Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care and Rapid Diagnostic as of 2024)
 Table 22. Ranking of Global Top Point of Care and Rapid Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Point of Care and Rapid Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Point of Care and Rapid Diagnostic, Headquarters and Area Served
 Table 25. Global Key Players of Point of Care and Rapid Diagnostic, Product and Application
 Table 26. Global Key Players of Point of Care and Rapid Diagnostic, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Point of Care and Rapid Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Point of Care and Rapid Diagnostic Revenue Market Share by Type (2020-2025)
 Table 30. Global Point of Care and Rapid Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Point of Care and Rapid Diagnostic Revenue Market Share by Type (2026-2031)
 Table 32. Global Point of Care and Rapid Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Point of Care and Rapid Diagnostic Revenue Market Share by Application (2020-2025)
 Table 34. Global Point of Care and Rapid Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Point of Care and Rapid Diagnostic Revenue Market Share by Application (2026-2031)
 Table 36. North America Point of Care and Rapid Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Point of Care and Rapid Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Point of Care and Rapid Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Point of Care and Rapid Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Point of Care and Rapid Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Point of Care and Rapid Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Point of Care and Rapid Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Point of Care and Rapid Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Point of Care and Rapid Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Point of Care and Rapid Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Point of Care and Rapid Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Point of Care and Rapid Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Point of Care and Rapid Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Point of Care and Rapid Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Point of Care and Rapid Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Roche Company Details
 Table 52. Roche Business Overview
 Table 53. Roche Point of Care and Rapid Diagnostic Product
 Table 54. Roche Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 55. Roche Recent Development
 Table 56. Abbott Company Details
 Table 57. Abbott Business Overview
 Table 58. Abbott Point of Care and Rapid Diagnostic Product
 Table 59. Abbott Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 60. Abbott Recent Development
 Table 61. LifeScan Company Details
 Table 62. LifeScan Business Overview
 Table 63. LifeScan Point of Care and Rapid Diagnostic Product
 Table 64. LifeScan Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 65. LifeScan Recent Development
 Table 66. Siemens Healthineers Company Details
 Table 67. Siemens Healthineers Business Overview
 Table 68. Siemens Healthineers Point of Care and Rapid Diagnostic Product
 Table 69. Siemens Healthineers Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 70. Siemens Healthineers Recent Development
 Table 71. Danaher Company Details
 Table 72. Danaher Business Overview
 Table 73. Danaher Point of Care and Rapid Diagnostic Product
 Table 74. Danaher Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 75. Danaher Recent Development
 Table 76. Ascensia Company Details
 Table 77. Ascensia Business Overview
 Table 78. Ascensia Point of Care and Rapid Diagnostic Product
 Table 79. Ascensia Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 80. Ascensia Recent Development
 Table 81. BioMerieux Company Details
 Table 82. BioMerieux Business Overview
 Table 83. BioMerieux Point of Care and Rapid Diagnostic Product
 Table 84. BioMerieux Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 85. BioMerieux Recent Development
 Table 86. ARKRAY Company Details
 Table 87. ARKRAY Business Overview
 Table 88. ARKRAY Point of Care and Rapid Diagnostic Product
 Table 89. ARKRAY Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 90. ARKRAY Recent Development
 Table 91. Bio-Rad Laboratories Company Details
 Table 92. Bio-Rad Laboratories Business Overview
 Table 93. Bio-Rad Laboratories Point of Care and Rapid Diagnostic Product
 Table 94. Bio-Rad Laboratories Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 95. Bio-Rad Laboratories Recent Development
 Table 96. Nova Biomedical Company Details
 Table 97. Nova Biomedical Business Overview
 Table 98. Nova Biomedical Point of Care and Rapid Diagnostic Product
 Table 99. Nova Biomedical Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 100. Nova Biomedical Recent Development
 Table 101. QuidelOrtho Company Details
 Table 102. QuidelOrtho Business Overview
 Table 103. QuidelOrtho Point of Care and Rapid Diagnostic Product
 Table 104. QuidelOrtho Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 105. QuidelOrtho Recent Development
 Table 106. Accriva Company Details
 Table 107. Accriva Business Overview
 Table 108. Accriva Point of Care and Rapid Diagnostic Product
 Table 109. Accriva Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 110. Accriva Recent Development
 Table 111. OraSure Technologies Company Details
 Table 112. OraSure Technologies Business Overview
 Table 113. OraSure Technologies Point of Care and Rapid Diagnostic Product
 Table 114. OraSure Technologies Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 115. OraSure Technologies Recent Development
 Table 116. Helena Laboratories Company Details
 Table 117. Helena Laboratories Business Overview
 Table 118. Helena Laboratories Point of Care and Rapid Diagnostic Product
 Table 119. Helena Laboratories Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 120. Helena Laboratories Recent Development
 Table 121. Phamatech Company Details
 Table 122. Phamatech Business Overview
 Table 123. Phamatech Point of Care and Rapid Diagnostic Product
 Table 124. Phamatech Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 125. Phamatech Recent Development
 Table 126. Chembio Diagnostics Company Details
 Table 127. Chembio Diagnostics Business Overview
 Table 128. Chembio Diagnostics Point of Care and Rapid Diagnostic Product
 Table 129. Chembio Diagnostics Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 130. Chembio Diagnostics Recent Development
 Table 131. Trinity Biotech Company Details
 Table 132. Trinity Biotech Business Overview
 Table 133. Trinity Biotech Point of Care and Rapid Diagnostic Product
 Table 134. Trinity Biotech Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 135. Trinity Biotech Recent Development
 Table 136. Wuhan Easy Diagnosis Company Details
 Table 137. Wuhan Easy Diagnosis Business Overview
 Table 138. Wuhan Easy Diagnosis Point of Care and Rapid Diagnostic Product
 Table 139. Wuhan Easy Diagnosis Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 140. Wuhan Easy Diagnosis Recent Development
 Table 141. Intec PRODUCT Company Details
 Table 142. Intec PRODUCT Business Overview
 Table 143. Intec PRODUCT Point of Care and Rapid Diagnostic Product
 Table 144. Intec PRODUCT Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 145. Intec PRODUCT Recent Development
 Table 146. Sinocare Company Details
 Table 147. Sinocare Business Overview
 Table 148. Sinocare Point of Care and Rapid Diagnostic Product
 Table 149. Sinocare Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 150. Sinocare Recent Development
 Table 151. Wondfo Company Details
 Table 152. Wondfo Business Overview
 Table 153. Wondfo Point of Care and Rapid Diagnostic Product
 Table 154. Wondfo Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 155. Wondfo Recent Development
 Table 156. Getein Biotech Company Details
 Table 157. Getein Biotech Business Overview
 Table 158. Getein Biotech Point of Care and Rapid Diagnostic Product
 Table 159. Getein Biotech Revenue in Point of Care and Rapid Diagnostic Business (2020-2025) & (US$ Million)
 Table 160. Getein Biotech Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Point of Care and Rapid Diagnostic Picture
 Figure 2. Global Point of Care and Rapid Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Point of Care and Rapid Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Blood Glucose Testing Features
 Figure 5. Infectious Diseases Testing Features
 Figure 6. Cardiac Markers Testing Features
 Figure 7. Coagulation Testing Features
 Figure 8. Pregnancy and Fertility Testing Features
 Figure 9. Blood Gas/Electrolytes Testing Features
 Figure 10. Urinalysis Testing Features
 Figure 11. Other Features
 Figure 12. Global Point of Care and Rapid Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Point of Care and Rapid Diagnostic Market Share by Application: 2024 VS 2031
 Figure 14. Hospitals Case Studies
 Figure 15. Clinic Case Studies
 Figure 16. Laboratory Case Studies
 Figure 17. Other Case Studies
 Figure 18. Point of Care and Rapid Diagnostic Report Years Considered
 Figure 19. Global Point of Care and Rapid Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Point of Care and Rapid Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Point of Care and Rapid Diagnostic Market Share by Region: 2024 VS 2031
 Figure 22. Global Point of Care and Rapid Diagnostic Market Share by Players in 2024
 Figure 23. Global Top Point of Care and Rapid Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care and Rapid Diagnostic as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Point of Care and Rapid Diagnostic Revenue in 2024
 Figure 25. North America Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Point of Care and Rapid Diagnostic Market Share by Country (2020-2031)
 Figure 27. United States Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Point of Care and Rapid Diagnostic Market Share by Country (2020-2031)
 Figure 31. Germany Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Point of Care and Rapid Diagnostic Market Share by Region (2020-2031)
 Figure 39. China Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Point of Care and Rapid Diagnostic Market Share by Country (2020-2031)
 Figure 47. Mexico Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Point of Care and Rapid Diagnostic Market Share by Country (2020-2031)
 Figure 51. Turkey Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Point of Care and Rapid Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Roche Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 55. Abbott Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 56. LifeScan Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 57. Siemens Healthineers Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 58. Danaher Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 59. Ascensia Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 60. BioMerieux Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 61. ARKRAY Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 63. Nova Biomedical Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 64. QuidelOrtho Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 65. Accriva Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 66. OraSure Technologies Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 67. Helena Laboratories Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 68. Phamatech Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 69. Chembio Diagnostics Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 70. Trinity Biotech Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 71. Wuhan Easy Diagnosis Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 72. Intec PRODUCT Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 73. Sinocare Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 74. Wondfo Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 75. Getein Biotech Revenue Growth Rate in Point of Care and Rapid Diagnostic Business (2020-2025)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Secure Hospital Communications Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H6366
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Direct To Consumer Telehealth Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I2436
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Healthcare API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10N6171
Thu Sep 11 00:00:00 UTC 2025

Add to Cart